Notice of Proposed Sale · 144
Veeva Systems Inc.
VEEVNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Veeva Systems Inc.
- Issuer CIK
- 0001393052
- SEC file number
- 001-36121
- Phone
- 9254526500
- Person for whose account securities are to be sold
- THOMAS SCHWENGER
- Relationships to issuer
- Officer
- Street
- 4280 Hacienda Drive
- City
- Pleasanton
- State / country code
- CA
- Postal code
- 94588
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 5,000 | 968,350.00 | 162,443,291 | 07/16/2026 | NYSE | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 04/01/2022 | Restricted Stock Units | Issuer | 5,000 | N | 04/01/2022 | N/A |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
The securities to be sold were acquired upon the vesting of restricted stock units during the period of 04/01/2022 through 04/01/2024.
Notice signature
- Notice date
- 07/16/2026
- Signed
- /s/ Thomas Schwenger
- Plan adoption dates
- 10/14/2025
Company context
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com.